Peptides · Peptide comparison
AOD-9604 vs Semaglutide
A modified fragment of human growth hormone that targets fat cells for breakdown without affecting blood sugar or muscle growth—your metabolism's precision tool.
The revolutionary once-weekly GLP-1 medication that helps your body feel full faster and longer, leading to significant weight loss while also protecting your heart—FDA approved and backed by some of the largest clinical trials in obesity medicine history.
- Weight Management
- Weight Management
At a glance
Quick comparison
Efficacy
Benefit ratings
Fat Targeting
Safety Profile
Joint Support
Weight Loss
Appetite Control
Heart Protection
Technical data
Compound specifications
AOD-9604
- Molecular formula
- C78H123N23O23S2
- Molecular weight
- 1815.1 g/mol
- Half-life
- ~3-4 minutes (plasma)
- Bioavailability
- High (subcutaneous)
- CAS number
- 221231-10-3
Semaglutide
- Molecular formula
- C187H291N45O59
- Molecular weight
- 4113.58 g/mol
- Half-life
- Approximately 7 days (168 hours)
- Bioavailability
- 89% (subcutaneous); 0.4-1% (oral, with absorption enhancer)
- CAS number
- 910463-68-2
Protocols
Dosing compared
AOD-9604
Subcutaneous
- 250 mcgOnce daily · 2-4 weeksAOD9604 is a research peptide and not an approved medicine. Doses around 250 mcg under the skin are a common starting point in practice. In a human trial the most effective amount was about 1 mg per day. [1][5]
- 300-400 mcgOnce daily · 8-12 weeksA commonly used daily amount in practice. The largest human study found benefit up to about 1 mg/day with no extra gain from higher doses. [1][5]
- 500 mcgOnce daily · 8-12 weeksA higher amount sometimes used in practice. Going above roughly 1 mg/day did not improve results in the human trial. [1][5]
Semaglutide
Subcutaneous
- 4 weeks0.25 mgOnce weekly · 4 weeksThis is the starter dose to help your body adjust. It does not lower blood sugar much on its own, so it is only used for the first 4 weeks before stepping up [5].
- At least 4 weeks at each step0.5-1 mgOnce weekly · At least 4 weeks at each stepAfter the starter month, the dose goes up to 0.5 mg, and can rise to 1 mg if more blood sugar control is needed. Wait at least 4 weeks before each increase [5].
- Ongoing/maintenance2-2.4 mgOnce weekly · Ongoing/maintenanceThe highest weekly doses. 2 mg is the maximum for diabetes (Ozempic) [5]; up to 2.4 mg is used for weight management (Wegovy) after a slower titration.
Oral
- 30 days3 mgOnce daily · 30 daysThe pill form (Rybelsus) starts at 3 mg each morning for 30 days. Like the starter shot, this dose is for getting started and does not control blood sugar by itself. Take on an empty stomach with a small sip of water, 30 minutes before food or other pills [6].
- 30+ days7 mgOnce daily · 30+ daysAfter the first 30 days, the dose increases to 7 mg once daily. This is the first dose that actively lowers blood sugar [6].
- Ongoing/maintenance14 mgOnce daily · Ongoing/maintenanceThe highest pill dose, used if more blood sugar control is needed after at least 30 days at 7 mg [6].
Applications
Best suited for
AOD-9604
- Targeted Fat Loss
- AOD-9604 shines when you want to target stubborn fat deposits. It works by mimicking how growth hormone breaks down fat, but without the side effects of actual HGH. Think of it as a smart missile that targets fat cells specifically.
- Body Recomposition
- Perfect for those who want to lose fat while maintaining muscle. Unlike many fat loss compounds, AOD-9604 doesn't affect muscle tissue or mess with your blood sugar levels—it's laser-focused on fat metabolism.
- Metabolic Enhancement
- Ideal for boosting your metabolism naturally. AOD-9604 increases fat oxidation (your body's ability to burn fat for fuel) without the jittery stimulant effects of caffeine or other thermogenics.
- Joint Health Support
- Emerging research shows AOD-9604 may help repair cartilage and support joint health. Studies in osteoarthritis models show it can reduce cartilage damage, making it a dual-purpose peptide for active individuals.
- Metabolically Safe Fat Loss
- Unlike many weight loss compounds, AOD-9604 doesn't raise blood sugar, doesn't affect insulin, and doesn't stimulate cell growth. It's one of the gentlest approaches to enhancing fat metabolism available.
Semaglutide
- People with Obesity Seeking Significant Weight Loss
- If your BMI is 30 or higher (or 27+ with weight-related health conditions), semaglutide is currently one of the most effective non-surgical weight loss options available. [7] Clinical trials show average weight loss of 15% of body weight—that's 30+ pounds for someone starting at 200 pounds [1].
- Those Who've Struggled with Diet and Exercise Alone
- Semaglutide works by changing the biological signals that drive hunger and cravings. If you've tried to lose weight through willpower alone and found yourself constantly battling hunger, this medication addresses that underlying biology rather than just telling you to eat less [3][7][13].
- People with Type 2 Diabetes Needing Better Control
- Originally developed for diabetes, semaglutide excellently controls blood sugar while also promoting weight loss—addressing two major health concerns simultaneously. [3][5] It can often allow people to reduce or eliminate other diabetes medications [21].
- Individuals at High Cardiovascular Risk
- The SELECT trial proved that semaglutide reduces heart attacks, strokes, and cardiovascular death by 20% in people with obesity and existing heart disease—even without diabetes. It's one of the few weight loss medications proven to improve hard cardiovascular outcomes [2].
Safety profile
Side effects
AOD-9604
Common
- Injection site reactions
- Mild headache
- Flushing or warmth
Uncommon
- Fatigue
- Dizziness
Serious
- Allergic reaction
Semaglutide
Common
- Nausea
- Constipation or Diarrhea
- Decreased Appetite
- Vomiting
Uncommon
- Gallbladder Problems
- Hair Loss (Telogen Effluvium)
Serious
- Pancreatitis
- Thyroid Tumors (Theoretical Risk)
Research status
Safety & evidence
AOD-9604
- Evidence level
- Moderate human trials (Phase 1-2)
- FDA status
- Not FDA approved
- Safety overview
- AOD-9604 has been studied in multiple human clinical trials involving thousands of participants. The safety profile is notably clean—it doesn't affect blood sugar, insulin levels, or cause the typical side effects of growth hormone. Phase 2 trials showed it was well-tolerated even at doses higher than typically used. The most common side effects are mild and injection-site related.
Contraindications
- Pregnancy or breastfeeding
- Active cancer or history of cancer
- Known allergy to growth hormone-derived peptides
- Children and adolescents
Semaglutide
- Evidence level
- Strong human trials (Phase 3 or FDA approved)
- FDA status
- FDA approved for this use
- Safety overview
- Semaglutide has been studied in over 20,000 participants across multiple large clinical trials, making it one of the most thoroughly researched weight loss medications available. [1][2][8][9][10] The FDA approved it after rigorous review of safety data. While GI side effects are common (especially early on), serious side effects are rare. [1][7] The SELECT trial showed it actually reduces cardiovascular events, adding a safety benefit beyond just weight loss [2].
Contraindications
- Personal or family history of medullary thyroid carcinoma (MTC) [7]
- Multiple Endocrine Neoplasia syndrome type 2 (MEN2) [7]
- History of serious allergic reaction to semaglutide [7]
Decision guide
Which is right for you?
AOD-9604
Choose AOD-9604 if…
- Fat loss
- Body composition improvement
- Metabolic support
- Joint health support
Semaglutide
Choose Semaglutide if…
- Significant weight loss
- Long-term weight management
- Cardiovascular risk reduction
- Blood sugar control